Triglyceride–Glucose Index as a Predictor of No-Reflow Phenomenon After Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction: Systematic Review and Meta-Analysis
Keywords:
Triglyceride–glucose index, TyG index, no-reflow phenomenon, ST-segment elevation myocardial infarction, percutaneous coronary interventionAbstract
Introduction: No-reflow phenomenon remains an important complication after percutaneous coronary intervention in ST-segment elevation myocardial infarction, reflecting impaired myocardial reperfusion despite successful epicardial vessel opening. The triglyceride–glucose index is a simple surrogate marker of insulin resistance and metabolic dysfunction, but its overall association with no-reflow after PCI remains incompletely established.
Objective: This systematic review and meta-analysis aimed to evaluate the predictive value of the triglyceride–glucose index for no-reflow or impaired microcirculatory reperfusion after PCI in patients with STEMI.
Methods: A systematic literature search was performed in PubMed, Cochrane Library, and ScienceDirect using terms related to triglyceride–glucose index, myocardial infarction, acute coronary syndrome, and percutaneous coronary intervention. Eligible studies included patients with STEMI or closely related AMI populations undergoing PCI, evaluated TyG index as a predictor, and reported no-reflow or impaired microcirculatory reperfusion outcomes. Odds ratios and 95% confidence intervals were pooled using a random-effects model.
Results: Five studies involving 2,007 patients were included. All studies were retrospective cohorts. Higher TyG index was consistently associated with increased risk of no-reflow or impaired microcirculatory reperfusion. The pooled analysis showed that elevated TyG index significantly increased the odds of no-reflow after PCI (OR 3.10, 95% CI 1.97–4.88; p<0.00001). Substantial heterogeneity was observed across studies (I²=85%), likely due to differences in population characteristics, no-reflow definitions, TyG cut-off values, and adjustment models.
Discussion: The association between TyG index and no-reflow is biologically plausible because insulin resistance, hyperglycemia, and hypertriglyceridemia may promote endothelial dysfunction, oxidative stress, inflammation, platelet activation, and microvascular obstruction. These mechanisms overlap with the pathophysiology of no-reflow after PCI. The TyG index may therefore represent a practical and low-cost marker for identifying patients at increased risk of reperfusion failure.
Conclusion: Higher TyG index is significantly associated with increased odds of no-reflow or impaired microcirculatory reperfusion after PCI in patients with STEMI. The TyG index may be useful for early risk stratification, although prospective validation is required before routine clinical implementation.
References
Rezkalla SH, Stankowski RV, Hanna J, Kloner RA. Management of No-Reflow Phenomenon in the Catheterization Laboratory. JACC: Cardiovascular Interventions. 2017 Feb;10(3):215–23. doi:10.1016/j.jcin.2016.11.059
Thiele H, Barbato E, Barthelemy O, Bauersachs J, Bhatt DL. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
Kunamalla A, Schaer GL. Advances in our Understanding and Treatment of the No-Reflow Phenomenon After PCI for STEMI. Cardiovascular Revascularization Medicine. 2022 Apr;37:102–4. doi:10.1016/j.carrev.2022.01.018
Tahapary DL, Pratisthita LB, Fitri NA, Marcella C, Wafa S, Kurniawan F, et al. Challenges in the diagnosis of insulin resistance: Focusing on the role of HOMA-IR and Tryglyceride/glucose index. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2022 Aug;16(8):102581. doi:10.1016/j.dsx.2022.102581
Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018 Dec;17(1):122. doi:10.1186/s12933-018-0762-4
Konijnenberg LSF, Damman P, Duncker DJ, Kloner RA, Nijveldt R, Van Geuns RJM, et al. Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction. Cardiovascular Research. 2020 Mar 1;116(4):787–805. doi:10.1093/cvr/cvz301
Park K, Ahn CW, Lee SB, Kang S, Nam JS, Lee BK, et al. Elevated TyG Index Predicts Progression of Coronary Artery Calcification. Diabetes Care. 2019 Aug 1;42(8):1569–73. doi:10.2337/dc18-1920
Luo E, Wang D, Yan G, Qiao Y, Liu B, Hou J, et al. High triglyceride–glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention. Cardiovasc Diabetol. 2019 Dec;18(1):150. doi:10.1186/s12933-019-0957-3
Kerkutluoglu M, Celik E, Dagli M, Gunes H. No-reflow phenomenon and triglyceride-glucose index in acute myocardial infarction. J CLIN MED KAZ. 2023 Aug 29;20(4):27–32. doi:10.23950/jcmk/13502
Ma J, Wu P, Ma S, Ma X, Jin P, Jia S. The triglyceride–glucose index is associated with no-reflow phenomenon in STEMI patients with type 2 diabetes after percutaneous coronary intervention. Front Cardiovasc Med. 2024 Sep 12;11:1386318. doi:10.3389/fcvm.2024.1386318
Yang J, Xu D, Liu X, Zhao Z, Zhang J. The triglyceride-glucose index and neutrophil-to-lymphocyte ratio jointly predict the no-reflow phenomenon in T2DM patients with STEMI after primary PCI. Al-Nimer MS, editor. PLoS One. 2026 Mar 20;21(3):e0345466. doi:10.1371/journal.pone.0345466
Qu Z. Predictive value of the triglyceride-glucose index for no-reflow phenomenon after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction complicated by metabolic syndrome. Am J Transl Res. 2024;16(10):5539–51. doi:10.62347/HQVS4428
Wang G, Xu C, Wang J, Teng Z, Sha X, Xu K, et al. Triglyceride-glucose index is associated with microcirculatory resistance in patients with type 2 diabetes and STEMI undergoing primary PCI. Sci Rep. 2025 Feb 8;15(1):4723. doi:10.1038/s41598-025-89269-6
Caiazzo G, Musci RL, Frediani L, Umińska J, Wanha W, Filipiak KJ, et al. State of the Art. Cardiology Clinics. 2020 Nov;38(4):563–73. doi:10.1016/j.ccl.2020.07.001
Ndrepepa G, Kastrati A. Coronary No-Reflow after Primary Percutaneous Coronary Intervention—Current Knowledge on Pathophysiology, Diagnosis, Clinical Impact and Therapy.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Mira Novia Iskandar, Schasett Augustiasmi Sumantri, Fatchurochman (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors publishing here keep copyright but grant the journal first publication rights, under a Creative Commons Attribution-NonCommercial 4.0 License. They can distribute their work non-exclusively elsewhere with an acknowledgment of its first publication in this journal. Posting the work online before and during submission for earlier and greater citation is encouraged, reflecting Open Access benefits.
